 |
MIDDLETON, Wis., July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Marie represents a paradigm shift in the delivery of particle therapy, combining an upright patient positioning system and a CT scanner that reimagines the treatment experience for both patients and clinicians, whilst drastically reducing the size and cost compared to existing particle therapy solutions.
"This clearance marks a major milestone not just for Leo Cancer Care, but for the future of cancer treatment," said Stephen Towe, CEO of Leo Cancer Care. "We've long believed there's a better, more human way to deliver radiotherapy. One that puts the patient at the heart of the treatment experience and embraces smarter, more compassionate design. Marie is the embodiment of that belief."
Particle therapies such as proton and carbon ion therapy have long been considered the gold standard in radiation oncology. However, the cost, size, and complexity of conventional systems with large rotating gantries have historically limited widespread adoption.
Leo Cancer Care's upright solution addresses these barriers. By rotating the patient rather than the beam, Marie eliminates the need for a rotating gantry, dramatically reducing infrastructure costs, simplifying installation, and expanding access to this advanced level of care.
Marie is particle beam-agnostic, meaning it's compatible with a wide range of current and emerging treatment modalities, including proton, carbon ion, BNCT and FLASH therapies. Its upright design opens new possibilities for treatment planning and delivery, particularly for tumors in the thoracic and abdominal regions. When compared to supine treatments, evidence suggests anatomical shifts are reduced due to the gravitational direction.
Through collaborations with leading hospitals around the world, Leo Cancer Care is conducting clinical research and trials, laying a strong foundation for the widespread adoption of upright therapy as a new standard in radiotherapy.
"We are incredibly proud of the teams and collaborators who helped bring Marie to life," added Thomas 'Rock' Mackie, Co-founder and Board Chairman of Leo Cancer Care. "This is just the beginning. We're working closely with leading particle beam companies and institutions worldwide to explore how upright positioning can unlock new levels of precision and personalization in cancer care."
Media Contact:
Fiona Redford
Head of Marketing
Leo Cancer Care
fiona@leocancercare.com
MIDDLETON, Wis., July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Marie represents a paradigm shift in the delivery of particle therapy, combining an upright patient positioning system and a CT scanner that reimagines the treatment experience for both patients and clinicians, whilst drastically reducing the size and cost compared to existing particle therapy solutions.
"This clearance marks a major milestone not just for Leo Cancer Care, but for the future of cancer treatment," said Stephen Towe, CEO of Leo Cancer Care. "We've long believed there's a better, more human way to deliver radiotherapy. One that puts the patient at the heart of the treatment experience and embraces smarter, more compassionate design. Marie is the embodiment of that belief."
Particle therapies such as proton and carbon ion therapy have long been considered the gold standard in radiation oncology. However, the cost, size, and complexity of conventional systems with large rotating gantries have historically limited widespread adoption.
Leo Cancer Care's upright solution addresses these barriers. By rotating the patient rather than the beam, Marie eliminates the need for a rotating gantry, dramatically reducing infrastructure costs, simplifying installation, and expanding access to this advanced level of care.
Marie is particle beam-agnostic, meaning it's compatible with a wide range of current and emerging treatment modalities, including proton, carbon ion, BNCT and FLASH therapies. Its upright design opens new possibilities for treatment planning and delivery, particularly for tumors in the thoracic and abdominal regions. When compared to supine treatments, evidence suggests anatomical shifts are reduced due to the gravitational direction.
Through collaborations with leading hospitals around the world, Leo Cancer Care is conducting clinical research and trials, laying a strong foundation for the widespread adoption of upright therapy as a new standard in radiotherapy.
"We are incredibly proud of the teams and collaborators who helped bring Marie to life," added Thomas 'Rock' Mackie, Co-founder and Board Chairman of Leo Cancer Care. "This is just the beginning. We're working closely with leading particle beam companies and institutions worldwide to explore how upright positioning can unlock new levels of precision and personalization in cancer care."
Media Contact:
Fiona Redford
Head of Marketing
Leo Cancer Care
fiona@leocancercare.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Leo Cancer Care Receives FDA 510(k) Clearance for Marie® - A Revolutionary Upright Radiotherapy Platform
|
PANAMA CITY, Jan. 16, 2026 /PRNewswire/ -- BingX, a leading crypto exchange and Web3-AI company, today announced a multi-year partnership with Scuderia Ferrari HP, marking BingX's first motorsport collaboration and Scuderia Ferrari HP's first-ever collaboration with a crypto exchange brand. This historic alliance brings together two global brands known for pushing the boundaries of performance and innovation.
Partnering with Scuderia Ferrari HP marks a defining milestone in BingX's global expansion strategy. As one of the world's most iconic motorsport teams, Scuderia Ferrari HP embodies precision, ambition, and continuous pursuit of excellence, values that mirror BingX's vision as it continues to scale its platform and community. The collaboration solidifies BingX's position as a top-of-mind brand in the crypto landscape and signals the company's long-term commitment to world-class partnerships and innovation.
Daniel Lai, Chief Business Officer at BingX, commented: "This partnership is more than a landmark. Partnering with Scuderia Ferrari HP sets a new benchmark for BingX. Scuderia Ferrari HP's discipline, precision, and relentless pursuit of excellence mirror the values we strive for as a global exchange. This partnership challenges us to elevate everything we build, every experience we deliver, and every user we serve around the world."
Lorenzo Giorgetti, Chief Racing Revenue Officer of Scuderia Ferrari HP said: "We are pleased to welcome BingX as Scuderia Ferrari HP's first crypto exchange partner. This collaboration reflects our willingness to embrace emerging technologies that align with our forward-looking philosophy. As we approach a new era in motorsport with the 2026 FIA regulations, this alliance demonstrates our readiness to explore cutting-edge innovation both on and off the track, while remaining true to our heritage of precision and pursuit of excellence. By selecting BingX as our first partner in the crypto exchange space, we recognize the transformative potential of this sector and the opportunity to connect with wider global audiences through new digital experiences."
Over the coming years, fans can expect to engage with BingX across a variety of Scuderia Ferrari HP events, digital platforms, global content, and exclusive experiences as the partnership evolves. This multi-year collaboration sets the tone for a new period of global ambition for BingX: One defined by breakthrough partnerships, world-class brand alignment, and a commitment to shaping the future of the industry.
About BingX
Founded in 2018, BingX is a leading crypto exchange and Web3-AI company, serving a global community of over 40 million users. With a comprehensive suite of AI-powered products and services, including derivatives, spot trading, and copy trading, BingX caters to the evolving needs of users across all experience levels, from beginners to professionals. Committed to building a trustworthy and intelligent trading platform, BingX empowers users with innovative tools designed to enhance performance and confidence. BingX has been the principal partner of Chelsea Football Club since 2024 and became the first official crypto exchange partner of Scuderia Ferrari HP in 2026.
For more information, please visit: https://bingx.com/
PANAMA CITY, Jan. 16, 2026 /PRNewswire/ -- BingX, a leading crypto exchange and Web3-AI company, today announced a multi-year partnership with Scuderia Ferrari HP, marking BingX's first motorsport collaboration and Scuderia Ferrari HP's first-ever collaboration with a crypto exchange brand. This historic alliance brings together two global brands known for pushing the boundaries of performance and innovation.
Partnering with Scuderia Ferrari HP marks a defining milestone in BingX's global expansion strategy. As one of the world's most iconic motorsport teams, Scuderia Ferrari HP embodies precision, ambition, and continuous pursuit of excellence, values that mirror BingX's vision as it continues to scale its platform and community. The collaboration solidifies BingX's position as a top-of-mind brand in the crypto landscape and signals the company's long-term commitment to world-class partnerships and innovation.
Daniel Lai, Chief Business Officer at BingX, commented: "This partnership is more than a landmark. Partnering with Scuderia Ferrari HP sets a new benchmark for BingX. Scuderia Ferrari HP's discipline, precision, and relentless pursuit of excellence mirror the values we strive for as a global exchange. This partnership challenges us to elevate everything we build, every experience we deliver, and every user we serve around the world."
Lorenzo Giorgetti, Chief Racing Revenue Officer of Scuderia Ferrari HP said: "We are pleased to welcome BingX as Scuderia Ferrari HP's first crypto exchange partner. This collaboration reflects our willingness to embrace emerging technologies that align with our forward-looking philosophy. As we approach a new era in motorsport with the 2026 FIA regulations, this alliance demonstrates our readiness to explore cutting-edge innovation both on and off the track, while remaining true to our heritage of precision and pursuit of excellence. By selecting BingX as our first partner in the crypto exchange space, we recognize the transformative potential of this sector and the opportunity to connect with wider global audiences through new digital experiences."
Over the coming years, fans can expect to engage with BingX across a variety of Scuderia Ferrari HP events, digital platforms, global content, and exclusive experiences as the partnership evolves. This multi-year collaboration sets the tone for a new period of global ambition for BingX: One defined by breakthrough partnerships, world-class brand alignment, and a commitment to shaping the future of the industry.
About BingX
Founded in 2018, BingX is a leading crypto exchange and Web3-AI company, serving a global community of over 40 million users. With a comprehensive suite of AI-powered products and services, including derivatives, spot trading, and copy trading, BingX caters to the evolving needs of users across all experience levels, from beginners to professionals. Committed to building a trustworthy and intelligent trading platform, BingX empowers users with innovative tools designed to enhance performance and confidence. BingX has been the principal partner of Chelsea Football Club since 2024 and became the first official crypto exchange partner of Scuderia Ferrari HP in 2026.
For more information, please visit: https://bingx.com/
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
BingX Becomes Scuderia Ferrari HP's First-Ever Crypto Exchange Partner
